Sherif Bakir
Cairo University, EgyptTitle: A step ahead neonatal protection through maternal immunization
Abstract
Immunization has played a crucial role in eliminating or reducing
the occurrence of devastating infections worldwide (Roush et al.,
2007; Andre et al., 2008).
Historically, the susceptibility of the fetus to infections was
believed to be due to the immaturity of the fetal immune system (1) and its
tendency to mount tolerogenic responses to antigens.
Maternal vaccination, a form of immunization for women
of childbearing age before, during or after pregnancy, aims at protecting the
mother against infections that may threaten healthy reproduction and allowing vaccine-induced
maternal antibodies to be transferred via placenta to the fetus and in
colostrum and breast milk to the infant for protection against diseases before
routine childhood immunization can be initiated.
Principles of
maternal vaccination
Maternal vaccination generates active innate, humoral
and cell-mediated immune protection in the mother to increase resistance
against infections and reduce the chance of vertical transmission of infections
to the fetus (Fig. 1A, left). In addition, maternal vaccination
elicits systemic immunoglobulin G (IgG) antibodies that can be transferred to
the fetus via the placenta in humans (Fig. 1A, middle and right) and mucosal IgG, IgA
and IgM antibodies that are secreted into the colostrum and milk and ingested
by the newborn during breastfeeding (Fig. 1B) to confer immune protection. Species vary
in the contribution each route makes to the transfer of immunity. In humans and
mice, maternal antibodies can be transferred via both routes.
Factors in favor of maternal immunization
•
Infants less than 6 months
are more vulnerable to viral and bacterial infections.
•
Immature immune system in
neonates and infants.
•
Need for multiple doses in
infants versus single maternal.
•
Adequate maternal immune
response.
•
Safety of maternally
derived antibodies.
•
Protection during
vulnerable period until immune responses are adequate to natural infection or
immunization.
Potential
problems of maternal immunization
•
Safety for mothers and
fetuses and need for exhaustive evaluation of candidate vaccines.
•
Lack of protection of
premature born infants <36 wks
•
Unknown effects on infants
immune responses to natural infection or active immunizations.
•
Legal and regulatory
issues.
Conclusion
•
Neonates and children under 1 year are more vulnerable to infectious
diseases.
•
Maternal immunization during the last trimester confers good
protection for both mothers and babies against many hazardous diseases.
Biography
TBA